On Wednesday, the U.S. Food and Drug Administration (FDA) approved Regeneron Pharmaceuticals Inc.’s (NASDAQ: REGN) Eylea HD (aflibercept) Injection 8 mg for patients with macular edema following ...
Regeneron Pharmaceuticals received approval from the U.S. Food and Drug Administration for its eye treatment Eylea HD. The approval is for Eylea to treat macular edema following retinal vein occlusion ...
In a bid to deepen its manufacturing foothold in the U.S., Regeneron Pharmaceuticals in April pledged production and infrastructure investments surpassing $7 billion across North Carolina and its ...
SARATOGA SPRINGS, N.Y. — Gov. Kathy Hochul recently announced that Regeneron Pharmaceuticals, a global leader in biotechnology founded in New York State, will create 1,000 new jobs as part of a $2 ...
ALBANY, N.Y. (NEWS10) — A global biotechnology company with roots in the Capital Region is expanding into Saratoga County with a new facility. Regeneron Pharmaceuticals’ new property on Duplainville ...
The former Quad Graphics property is seen on Thursday in Saratoga Springs. Drug development and manufacturing firm Regeneron is building a 1-million-square-foot facility on the site. (Will ...
Tarrytown-based Regeneron bought the former Avon complex at 1 Avon Place in Suffern in early 2024 for $38.875 million. The biotech company planned another $100 million in renovations at the site, ...
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...
Regeneron is buying in to Modex Therapeutics’ next-generation antibody platform with a $7 million upfront payment and a total potential deal value exceeding $1 billion. The New York-based biopharma ...
Oct 28 (Reuters) - Regeneron Pharmaceuticals (REGN.O), opens new tab beat Wall Street estimates for third-quarter results on Tuesday, helped by strong demand for its eczema treatment, Dupixent, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results